Comments on: A Phase 1/2 Study Evaluating the Safety and Efficacy of a Single Dose of Autologous CD34+ Base Edited Hematopoietic Stem Cells (BEAM-101) to Increase Fetal Hemoglobin (HbF) Production in Patients With Severe Sickle Cell Disease

Comments on: A Phase 1/2 Study Evaluating the Safety and Efficacy of a Single Dose of Autologous CD34+ Base Edited Hematopoietic Stem Cells (BEAM-101) to Increase Fetal Hemoglobin (HbF) Production in Patients With Severe Sickle Cell Disease https://scdstudies.com/a-phase-1-2-study-evaluating-the-safety-and-efficacy-of-a-single-dose-of-autologous-cd34-base-edited-hematopoietic-stem-cells-beam-101-to-increase-fetal-hemoglobin-hbf-production-in-patients-with/?utm_source=rss&utm_medium=rss&utm_campaign=a-phase-1-2-study-evaluating-the-safety-and-efficacy-of-a-single-dose-of-autologous-cd34-base-edited-hematopoietic-stem-cells-beam-101-to-increase-fetal-hemoglobin-hbf-production-in-patients-with Fri, 14 Jun 2024 12:17:19 +0000 hourly 1 https://wordpress.org/?v=6.7.1